Lava Therapeutics B.V.
Rob Roovers has worked for seven different companies since 1995. Rob began their career as a PhD student at CESAME in 1995. From 2000 to 2003, they worked as a Post-Doc at Antoni van Leeuwenhoek. Rob then moved to Ablynx, also as a Post-Doc, from 2003 to 2006. From 2006 to 2007, they were a Senior Post-Doc at VUmc. Rob then moved to Universiteit Utrecht, where they were a Senior Post-Doc from 2007 to 2011. From 2011 to 2018, they were an Associate Director at Merus N.V. Rob is currently a Sr. Director preclinical development at Lava Therapeutics B.V.
Rob Roovers completed their Master of Science (MSc) in Cell/Cellular and Molecular Biology at Radboud University from 1989 to 1995. Prior to that, they attended Mill-Hill college from 1983 to 1989 and received a VWO.
This person is not in any offices
Lava Therapeutics B.V.
Lava Therapeutics is focused on applying its expertise in gamma-delta T-cell engagers (TCEs) to transform cancer therapy.